Publicaciones en las que colabora con María Esteve Pardo (7)

2023

  1. I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease

    Clinical Gastroenterology and Hepatology, Vol. 21, Núm. 3, pp. 771-788.e10

2019

  1. Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial

    Therapeutic Advances in Gastroenterology, Vol. 12

  2. Differences between childhood- and adulthood-onset inflammatory bowel disease: the CAROUSEL study from GETECCU

    Alimentary Pharmacology and Therapeutics, Vol. 49, Núm. 4, pp. 419-428

2018

  1. Human intestinal pro-inflammatory CD11chighCCR2+CX3CR1+ macrophages, but not their tolerogenic CD11c-CCR2-CX3CR1- counterparts, are expanded in inflammatory bowel disease article

    Mucosal Immunology, Vol. 11, Núm. 4, pp. 1114-1126

2016

  1. Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients

    American Journal of Gastroenterology, Vol. 111, Núm. 10, pp. 1456-1465

2011

  1. Revisiting genome wide association studies (GWAS) in coeliac disease: Replication study in Spanish population and expression analysis of candidate genes

    Journal of Medical Genetics, Vol. 48, Núm. 7, pp. 493-496

2002

  1. Hypertransaminasemia in pediatric celiac disease patients and its prevalence as a diagnostic clue

    American Journal of Gastroenterology, Vol. 97, Núm. 12, pp. 3176-3181